OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,020.00
-120.00 (-1.68%)
Last updated: Oct 10, 2025, 12:33 PM KST
-1.68%
Market Cap110.16B
Revenue (ttm)82.81B
Net Income (ttm)9.51B
Shares Out16.15M
EPS (ttm)622.14
PE Ratio10.96
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,851
Average Volume170,935
Open7,140.00
Previous Close7,140.00
Day's Range6,890.00 - 7,140.00
52-Week Range4,855.00 - 8,960.00
Beta0.41
RSI29.35
Earnings DateOct 24, 2025

About OPTUS Pharmaceutical

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 159
Stock Exchange KOSDAQ
Ticker Symbol 131030
Full Company Profile

Financial Performance

In 2024, OPTUS Pharmaceutical's revenue was 81.90 billion, an increase of 13.09% compared to the previous year's 72.43 billion. Earnings were 10.31 billion, a decrease of -4.20%.

Financial Statements

News

There is no news available yet.